Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 244-251 , August 2010

Acral lesions in tuberous sclerosis complex: Insights into pathogenesis

  • Capt Shelley L. Aldrich, USAF, MC, MD

      Affiliations

    • Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • ,
  • Chien-Hui Hong, MD, MS

      Affiliations

    • Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
    • ,
  • Leslie Groves, BS

      Affiliations

    • Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • ,
  • Cara Olsen, DrPH

      Affiliations

    • Biostatistics Consulting Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • ,
  • Joel Moss, MD, PhD

      Affiliations

    • Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Thomas N. Darling, MD, PhD

      Affiliations

    • Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    • Corresponding Author InformationReprint requests: Thomas N. Darling, MD, PhD, Department of Dermatology, Uniformed Services University of Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814.

,Accepted 19 August 2009.

References 

  1. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–1356
  2. Darling TN. Hitting the mark in hamartoma syndromes. Adv Dermatol. 2006;22:181–200
  3. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–823
  4. Schwartz RA, Fernandez G, Kotulska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007;57:189–202
  5. Nickel WR, Reed WB. Tuberous sclerosis: special reference to the microscopic alterations in the cutaneous hamartomas. Arch Dermatol. 1962;85:209–226
  6. Aste N, Pau M, Aste N, Biggio P. Tuberous sclerosis with unusual giant ungual fibromas. J Eur Acad Dermatol Venereol. 2003;17:100–101
  7. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624–628
  8. Carlson RM, Lloyd KM, Campbell TE. Acquired periungual fibrokeratoma: a case report. Cutis. 2007;80:137–140
  9. Zeller J, Friedmann D, Clerici T, Revuz J. The significance of a single periungual fibroma: report of seven cases. Arch Dermatol. 1995;131:1465–1466
  10. Jozwiak S, Schwartz RA, Janniger CK, Michalowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37:911–917
  11. Nevin NC, Pearce WG. Diagnostic and genetical aspects of tuberous sclerosis. J Med Genet. 1968;5:273–280
  12. Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1–5
  13. Li S, Takeuchi F, Wang JA, Fan Q, Komurasaki T, Billings EM, et al. Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc Natl Acad Sci U S A. 2008;105:3539–3544
  14. Kint A, Baran R. Histopathologic study of Koenen tumors: are they different from acquired digital fibrokeratoma?. J Am Acad Dermatol. 1988;18:369–372
  15. Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, et al. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J Exp Med. 2005;202:617–624
  16. Steagall WK, Taveira-DaSilva AM, Moss J. Clinical and molecular insights into lymphangioleiomyomatosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(Suppl):S49–S66
  17. Sparling JD, Hong CH, Brahim JS, Moss J, Darling TN. Oral findings in 58 adults with tuberous sclerosis complex. J Am Acad Dermatol. 2007;56:786–790
  18. Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9:88–100
  19. Norman-Taylor F, Mayou BJ. Macrodactyly in tuberous sclerosis. J R Soc Med. 1994;87:419–420
  20. Lo WL, Wong CK. Localized pachydermodactyly in tuberous sclerosis. Clin Exp Dermatol. 1993;18:146–147
  21. Lin YC, Wu YH, Scher RK. Nail changes and association of osteoarthritis in digital myxoid cyst. Dermatol Surg. 2008;34:364–369
  22. Nicolopoulos J, Goodman GJ, Howard A. Diseases of the generative nail apparatus, part I: nail matrix. Australas J Dermatol. 2002;43:81–90
  23. Dowling RH. Sub-ungual splinter hemorrhages. Postgrad Med J. 1964;40:595–600
  24. de Berker DA, Perrin C, Baran R. Localized longitudinal erythronychia: diagnostic significance and physical explanation. Arch Dermatol. 2004;140:1253–1257
  25. Moon SE, Won JH, Kwon OS, Kim JA. Subungual glomus tumor: clinical manifestations and outcome of surgical treatment. J Dermatol. 2004;31:993–997
  26. Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992;126:275–282
  27. Cooper SM, Burge SM. Darier's disease: epidemiology, pathophysiology, and management. Am J Clin Dermatol. 2003;4:97–105
  28. Young JB, Will EJ, Mulley GP. Splinter hemorrhages: facts and fiction. J R Coll Physicians Lond. 1988;22:240–243
  29. Robert C, Faivre S, Raymond E, Armand JP, Escudier B. Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?. Ann Intern Med. 2005;143:313–314
  30. Autier J, Escudier B, Wechsler J, Spatz A, Robert C. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol. 2008;144:886–892
  31. Saladi RN, Persaud AN, Rudikoff D, Cohen SR. Idiopathic splinter hemorrhages. J Am Acad Dermatol. 2004;50:289–292
  32. Goodman GJ, Nicolopoulos J, Howard A. Diseases of the generative nail apparatus, part II: nail bed. Australas J Dermatol. 2002;43:157–170
  33. Butterworth T, Wilson M. Dermatologic aspects of tuberous sclerosis. Arch Dermatol Syph. 1941;43:1–41
  34. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol. 2001;117:1027–1035

 The first two authors contributed equally to this article.

 Supported by a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, R01 CA100907, and the Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01154-2

doi: 10.1016/j.jaad.2009.08.042

Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 244-251 , August 2010

Article Tools

* Image Usage & Resolution